Pioneering Pain-free Solutions
We leverage the power of medical technology to develop transformative, accurate solutions that improve the quality of life.
We are on a mission to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life.
Our Technology
Revolutionizing Drug Testing Through Fingerprint Sweat Analysis
Our innovative Intelligent Fingerprinting Drug Testing Solution detects commonly abused drugs via sweat from the fingertips. The system’s ease of use and portability make it a convenient solution for reliable drug screening and identification of potential misuse within the 16-24 hours before testing.
Fingerprint DRUG Testing
A Dignified Approach to Drug Testing
Our Intelligent Fingerprinting Drug Screening System tests fingertip sweat for recent drug use, including cannabis, cocaine, opiates, and methamphetamine. Samples are collected in less than one minute and results displayed in less than ten minutes.
Non-invasive Drug Monitoring
SmarTest® Sweat Drug Testing Patch
The SmarTest Patch is a discreet, wearable device that detects drug use through sweat over a 7 to 10-day period. Comfortable, tamper-evident, and water-resistant, it’s ideal for longer-term monitoring in justice and rehabilitation settings.
Used alongside our Intelligent Fingerprinting Drug Screening System, it offers a complete non-invasive sweat-based solution for both immediate and continuous drug detection.
INVESTOR RELATIONS
Transforming Testing Solutions Through Med Tech Innovation
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. Its Intelligent Fingerprinting Drug Testing Solution is currently being utilized across multiple industries, With recent FDA 510(k) submission in December of 2024 and entry into the US market planned for 2025, INBS is capitalizing on the rapidly growing drug screening products market.
Intelligent Bio Solutions News
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
Razor-razorblade business model accelerates, with Q3 cartridge revenue up 59% year-over-year, representing 66% of quarterly sales Nine-month revenue reaches $3.07 million, up 39% year-over-year, building on record first-half performance Gross
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
Validation study targets sub-3-minute results to capture global roadside testing market and significantly reduce analysis time from 10 minutes U.S. Roadside drug testing market projected to reach $1.62 billion by
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
INBS implements enhanced security architecture to protect test integrity and donor data, strengthening upcoming FDA 510(k) submission NEW YORK, April 17, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or